Lenvima (lenvatinib)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
WARNINGS AND PRECAUTIONS
Hypertension
In Study 2 in RCC, hypertension was reported in 42% of patients in the...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts